Payer Coverage Policies of Tumor Biomarker and Pharmacogenomic Testing (ADVI Report)
Assess and document payer coverage policies for tumor biomarker and pharmacogenomic testing to inform coverage advocacy.
Key Activities
ADVI-authored analysis of payer coverage policies for tumor biomarker and pharmacogenomic testing, commissioned to surface coverage gaps and inconsistencies.